| HOME >> MEDICINE >> TECHNOLOGY |
76$
76$
305$
305Royalty revenue9961,0053,8593,632Product sales3,6462,05811,7387,132Product sales to related party161160482681Total revenues4,8793,29916,38411,750Operating costs and expenses:Product costs1,6281,2705,4044,652Sales and marketing8521,1024,1435,138Research and development9231,3515,1384,935General and administrative2,4382,1149,5445,629Total operating costs and expenses5,8415,83724,22920,354Loss from operations(962)(2,538)(7,845)(8,604)Interest income, interest expense and other income (expense), net:Interest income12155640Interest expense(102)207288(149)Other income (expense), net10(2)1942Loss before income tax(1,042)(2,318)(7,482)(8,671)Income tax benefit (provision)—231(1)226Net loss$
(1,042)$
(2,087)$
(7,483)$
(8,445)Basic and diluted net loss per share:$
(0.02)$
(0.04)$
(0.14)$
(0.25)Weighted average shares used in computing basic and diluted net loss per share53,067,04553,067,05753,067,05233,594,033DIADEXUS, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(In thousands)December 31,2011December 31,2010AssetsCurrent assets:Cash and cash equivalents$
10,484$
20,394Short-term marketable securities6,492—Accounts receivable 2,4081,543Receivable from related party—175Inventories117105Restricted cash400—Assets held for sale304308Prepaid expenses and other current assets9751,046Total current assets21,18023,571Long-term investments250—Restricted cash1,4001,800Property and equipment, net1,350580Other long-term assets175128Total assets$
24,355$
26,079Liabilities and Stockholders' Equity Current liabilities:Accounts payable$
882$
445Deferred revenues, current portion331305Deferred rent, current portion—103Unfavorable lease obligations492363Notes payable, current portion372—Accrued and other current liabilities2,4691,930Total current liabilities4,5463,146Lon
'/>"/>
| SOURCE diaDexus, Inc. Copyright©2010 PR Newswire. All rights reserved |